MiRNA-155 regulates lymphangiogenesis in natural killer/T-cell lymphoma by targeting BRG1

Inhibition of miR-155, a therapeutic target for breast cancer, prevented in cancer stem cell formation

(2018) Jiangcheng Zuo et al.   Cancer Biomarkers

The diagnosis and management of NK/T-cell lymphomas

(2017) Eric Tse et al.   Journal of Hematology & Oncology

The BRG1 ATPase of human SWI/SNF chromatin remodeling enzymes as a driver of cancer

(2017) Qiong Wu et al.   Epigenomics

A role for BRG1 in the regulation of genes required for development of the lymphatic system

(2017) Ajeet Pratap Singh et al.   Oncotarget

Increased Brahma-related Gene 1 Expression Predicts Distant Metastasis and Shorter Survival in Patients with Invasive Ductal Carcinoma of the Breast

(2016) SUNG-IM DO et al.   ANTICANCER RESEARCH

Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers

(2016) Katrien Van Roosbroeck et al.   CLINICAL CANCER RESEARCH

Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project

(2016) A. M. Perry et al.   HAEMATOLOGICA

MicroRNA-155 is a potential molecular marker of natural killer/T-cell lymphoma

(2016) Xudong Zhang et al.   Oncotarget

The BRG1 chromatin remodeling enzyme links cancer cell metabolism and proliferation

(2016) Qiong Wu et al.   Oncotarget

BRG1 targeting STAT3/VEGFC signaling regulates lymphangiogenesis in colorectal cancer

(2016) Xu Zhu et al.   Oncotarget

Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project

(2016) A. M. Perry et al.   HAEMATOLOGICA

Receptor-type tyrosine-protein phosphatase   directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma

(2015) Y.-W. Chen et al.   BLOOD

Global Promoter Methylation Analysis Reveals Novel Candidate Tumor Suppressor Genes in Natural Killer Cell Lymphoma

(2015) C. Kucuk et al.   CLINICAL CANCER RESEARCH

The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation

(2015) Qiong Wu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

miR-155 Deficiency Ameliorates Autoimmune Inflammation of Systemic Lupus Erythematosus by TargetingS1pr1inFaslpr/lprMice

(2015) Qian Xin et al.   JOURNAL OF IMMUNOLOGY

Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma

(2015) Lu Jiang et al.   NATURE GENETICS

Brg-1 targeting of novel miR550a-5p/RNF43/Wnt signaling axis regulates colorectal cancer metastasis

(2015) G Wang et al.   ONCOGENE

Restoration of BRG1 inhibits proliferation and metastasis of lung cancer by regulating tumor suppressor miR-148b

(2015) Xianen Fa et al.   OncoTargets and Therapy

Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells

(2015) Can Küçük et al.   Nature Communications

Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type

(2015) Seungbok Lee et al.   Oncotarget

Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice

(2014) Oleg Butovsky et al.   ANNALS OF NEUROLOGY

BRG1/SMARCA4 Inactivation Promotes Non-Small Cell Lung Cancer Aggressiveness by Altering Chromatin Organization

(2014) T. Orvis et al.   CANCER RESEARCH

Seed targeting with tiny anti-miR-155 inhibits malignant progression of multiple myeloma cells

(2014) Maoxiao Feng et al.   JOURNAL OF DRUG TARGETING

The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma

(2014) Guido von Figura et al.   NATURE CELL BIOLOGY

Signaling for lymphangiogenesis via VEGFR-3 is required for the early events of metastasis

(2013) Masataka Matsumoto et al.   CLINICAL & EXPERIMENTAL METASTASIS

BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer

(2013) Jin Bai et al.   PLoS One

Comprehensive molecular portraits of human breast tumours

(2012) Daniel C. Koboldt et al.   NATURE

MicroRNA Profiling of Epstein-Barr Virus-Associated NK/T-Cell Lymphomas by Deep Sequencing

(2012) Natalie Motsch et al.   PLoS One

Janus Kinase 3–Activating Mutations Identified in Natural Killer/T-cell Lymphoma

(2012) Ghee Chong Koo et al.   Cancer Discovery

Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses

(2011) K. Karube et al.   BLOOD

BRM and BRG1 subunits of the SWI/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours

(2011) V.L. Bock et al.   BRITISH JOURNAL OF DERMATOLOGY

Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer

(2010) Pedro P. Medina et al.   Epigenetics

BRG1 mutations found in human cancer cell lines inactivate Rb-mediated cell-cycle arrest

(2010) Christopher Bartlett et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia

(2009) Y. Yamanaka et al.   BLOOD

MicroRNAs in Cancer: Small Molecules With a Huge Impact

(2009) Marilena V. Iorio et al.   JOURNAL OF CLINICAL ONCOLOGY

The SWI/SNF complex and cancer

(2009) D Reisman et al.   ONCOGENE

Non-nasal natural killer cell lymphoma: not non-nasal after all

(2008) Eric Tse et al.   ANNALS OF HEMATOLOGY

Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project

(2008) W.-y. Au et al.   BLOOD

Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines

(2008) Pedro P. Medina et al.   HUMAN MUTATION